Vanda Pharmaceuticals (VNDA) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.90% |
| Dec 31, 2025 | 110.03% |
| Sep 30, 2025 | 239.90% |
| Jun 30, 2025 | -134.78% |
| Mar 31, 2025 | 999.47% |
| Dec 31, 2024 | -66.88% |
| Sep 30, 2024 | 179.00% |
| Jun 30, 2024 | 16.23% |
| Mar 31, 2024 | 58.39% |
| Dec 31, 2023 | -223.94% |
| Sep 30, 2023 | 118.51% |
| Jun 30, 2023 | -201.92% |
| Mar 31, 2023 | 148.31% |
| Dec 31, 2022 | 446.37% |
| Sep 30, 2022 | -49.24% |
| Jun 30, 2022 | -234.29% |
| Mar 31, 2022 | 141.80% |
| Dec 31, 2021 | -56.73% |
| Sep 30, 2021 | 51.47% |
| Jun 30, 2021 | -48,242.25% |
| Mar 31, 2021 | 100.43% |
| Dec 31, 2020 | 65.12% |
| Sep 30, 2020 | -1,851.28% |
| Jun 30, 2020 | -86.54% |
| Mar 31, 2020 | 425.84% |
| Dec 31, 2019 | 55.10% |
| Sep 30, 2019 | -18.04% |
| Jun 30, 2019 | 67.75% |
| Mar 31, 2019 | -130.64% |
| Dec 31, 2018 | -77.47% |
| Sep 30, 2018 | 91.21% |
| Jun 30, 2018 | -720.79% |
| Mar 31, 2018 | 121.60% |
| Dec 31, 2017 | 36.21% |
| Sep 30, 2017 | 192.72% |
| Jun 30, 2017 | 66.05% |
| Mar 31, 2017 | -311.06% |
| Dec 31, 2016 | 243.50% |
| Sep 30, 2016 | 117.81% |
| Jun 30, 2016 | -83.99% |
| Mar 31, 2016 | -263.75% |
| Dec 31, 2015 | 1,682.08% |
| Sep 30, 2015 | -109.84% |
| Jun 30, 2015 | 108.45% |
| Mar 31, 2015 | -17.75% |
| Dec 31, 2014 | -598.83% |
| Sep 30, 2014 | -44.87% |
| Jun 30, 2014 | 2,565.04% |
| Mar 31, 2014 | 100.59% |
| Dec 31, 2013 | -938,414.29% |
| Sep 30, 2013 | -100.74% |
| Jun 30, 2013 | -96.88% |
| Mar 31, 2013 | 1,699.00% |
| Dec 31, 2012 | -109.39% |
| Sep 30, 2012 | 1,459.99% |
| Jun 30, 2012 | -105.17% |
| Mar 31, 2012 | -27.73% |
| Dec 31, 2011 | 133.46% |
| Sep 30, 2011 | 390.82% |
| Jun 30, 2011 | -73.65% |
| Mar 31, 2011 | 123.55% |
| Dec 31, 2010 | -47.20% |